Test Banyan

Opening Recap Market Pulse: Tech dragged the Nasdaq lower while energy names clung to gains after chatter about fresh tensions in the Middle East. Traders

FDA Rejection & Stock Impact Corcept Therapeutics (NASDAQ: CORT) is a commercial-stage biotech focused on cortisol-modulating drugs. The company is reeling from an unexpected FDA

Opening Recap Market Pulse: Canada’s TSX barely budged, save for a lone space-and-defence stock that ripped away from the pack, while a drone tech maker